Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The technicals dont matter; so please stop reading the chart and figuring out where it goes next. The MM's are fully in control and going to take it anywhere they want it to go.
Ask yourself one simple question.....did anything fundamentally change with the company? If not, you have to ride out the day to day fluctuations and continue to believe in its potential.
The savvy investors will continue to add...as buying in the darkest days will reap big rewards.
Its very possible; but I would like to see a weighted average (over several trading days)....as Friday was the last trading day (before the three day holiday weekend). I hope you are right; as if these numbers can hold on this coming Tuesday and Wed....it might be a sign that the short selling has exhausted itself.
You have a very compelling question; however, I am not versed nor knowledgeable to answer your question correctly. Perhaps our on board resident and expert...."Dr. Jerry" is capable of answering this question
Good post: the company's ability to plow funds into retiring old debts instead of using them for drugs and/or diagnostic products tells me they are very confident with future financing.
I dont know if it will be a JV or Partnership.....but there will be many interested parties (could be venture capital, investment bankers or perhaps a company that will license one of their products).
If it just a matter of time until news hits.....patience is a virtue.
Chairmans blog is definitely due for a monthly update. I am sure it will happen this week....so many catalysts in play too. We could see a PR frenzy over the next 60 days.
Is that your speculative guess...or did Gerald actually state he will update shareholders with his blog tomorrow.
Just keeping facts as facts....>Thx.
Agree: this board is truly very interesting and entertaining. I just laugh at these individuals who believe in gloom and doom for MANF and the company. Then why do they post relentlessly over and over...wouldnt one just walk away and invest there time other places.
Disagree! ....and if you have watched or reviewed the CEO's presentations that he did at several recent conferences....he clearly states the market potential for these testing products (perhaps he is clueless).
BTW: Your viewpoints are extremely myopic...but I enjoy reading both good, bad or indifferent....as sharing information is always highly encouraged (to make us more informed investors one way or another).
You have so grossly understated the short and long term upside potential with their entire Diagnostics Portfolio (7 products centered around Parkinsons and Alzheimers and many others).
This company may be generating revenue as late as the end of 2013 or early 2014 (and will be north of 1 billion in sales once at least 2 or more get FDA approval).
To everyone...please do you own DD!!!
Agree! But its part of the process and game that's played with these small OTC stocks (as you know). It just requires patience, confidence and belief that Management can execute.
I am a BELIEVER!!!
I am expecting another significant shakeout before our flight takes off. The MM's are working our PPS to perfection... and I am not convinced they are done with there scare tactics.
Maybe we touch $.075 or $.07 on an intraday low and close green with strong buying support the remainder of the day.
The Consolidation bodes extremely well for a sharper advancement in the very near future too.
Nice Seeking Alpha article on MANF potential. However, I was pleasantly surprised that the IND wont happen until late 2014 or early 2015 (I wonder how accurate this timeline is....there next article will talk about the true underlying valuation of AMBS).
Typically, a small and young Biotech company (of this nature) will release excellent news; the PPS will rise nicely and then a Financing arrangement will announced....May will be a big month here ..as I believe some funding will be due back to Dominion and new funding will eventually need to replace those owed to Dominion.
We are suppressed at these levels because this issue needs resolution; I dont know why the smart money would drive this much higher (at this stage) of the development process knowing there just might be pending dilution.
I am LONG and have been accumulating every week (and will continue to do so). I really hope Gerald can pull non-dilutive financing off.....as this PPS will rise very sharply once the company becomes well funded (or a JV or Partnership is announced).
Next step: lets win some MJFF funding on the 20th of Feb...this could be huge (I am dreaming that it could be well in excess of $10mm or a lot more). Lastly, the Diagnostics business will be a HUGE cash flow machine....this is the Holy grail short and medium term here. GLTA!!!
Lets have a drink to one of the most transparent CEO's in America.
We did not close below the 50 day moving avg. Its $.078.....may see a dip tomorrow to trigger more stop loss orders but fundamentally this is one very strong company.
Believe in the Science.....the MM's will steal your shares at these ridiculous levels.....HOLD STRONG!!!
Agree! Its simple manipulation ..and the MM's will more than likely take this down further before it goes much higher. The fundamentals are strong and in place...love how the shorts, bears, degenerates claim victory after the stock goes down a little over a penny. Lol.
Triple bottom on the chart ...and closed on major support (at $.087). The chart has now turned bullish once again....going to new highs this time around...got to love Dr. Jerry's post and his respective connections.
The Diagnostic business is going to drive us higher and faster than MANF in the S/T. Here you go:
The Street ....will take 6x Sales = $125 million in US sales gives us a $750mm market cap (and thats for one Diagnostic test). If it goes global...the potential is 5 fold. So do the math...we could reach a $3.5 billion market cap and we are not even including MANF, TBI, Heart related indications (non Diagnostic drug possibilities).
Enjoy the ride and journey. GLTA!!!
Outstanding post. Really nice work here!!!
Agree> Its not dilutive financing for now. It was a was a savvy deal and decision to do so.
But remember, if $2 is the listing requirement....then you have drawn a conclusion that our market cap will be close to $500mm in a few months....a very tall order.
The only lid keeping our PPS from exploding is future financing. Moreover, I am hopeful that Gerald can continue to be creative with funding; but I dont think anything is guaranteed at this juncture going forward.
I am holding long and strong and have continued to accumulate just about every week since December....and will continue to do so. Lastly, I am looking for further test results validation and then more funding...then she goes on and upward. >GLTA
Does any research and simply establish that the market had profit taking across the board today. As of right now, this stock is primarily held by Insider and Retail investors. Therefore, it wont take much to driver it lower ....it will take an uplisting and institutional buying to support it and drive it higher (unless significant news hits at anytime).
Please forget about the day to day swings and the degenerates who are trying to drive it lower. Biotech stocks are extremely volatile too!!!
More funding announced, Science is proven, CEO is transparent, top notch Advisory board, a future Cash Flow machine with the Diagnostics business, and the most incredible MANF technology that could change the world.
Translation: Buy with open arms and consider it a gift that its has stayed down this low (for this long) >GLTA!!!
Funding is a very strong positive. Obviously, the company will need a lot more....but this is a great start to expand the original financing deal.
Bottom line: A great vote of confidence by the institutional crowd...more to come. GLTA!!!
Could see some S/T weakness based on further delays with clinical results validation. MANF program is the prize; but Longs need to realize that the Diagnostic portfolio is going to drive the PPS higher just as well.
In terms of Financing; I would like to see the company finish the CLIA validation testing for the Parkinsons and Alzheimers diagnostic tests '''''and bring them home to commercialization.
SSSSS = CASH FLOW to fund MANF!!!!
I saw this message on the Arrayit message board; the key quote is outlined right below:
"We are currently seeking a pharma or diagnostics strategic partner to advance PDx™ to a 510(k) FDA submission."
Newsletter from ARYC has more info on PDx test
by angel5734a . Jan 28, 2013 7:04 PM . Permalink
Courtesy of Mike Cr post on ihub:
"Parkinson's Disease featured in Arrayit Newsletter
Parkinson's Disease
Arrayit Corporation has utilized genomic expression profiling and advanced bioinformatics to decipher the molecular basis of Parkinson's Disease (PD). In a collaboration with The Parkinson's Institute (Sunnyvale, CA), we compared messenger RNA levels in PD patients and controls, and identified a subset of 30 cellular genes dramatically up- and down-regulated in a PD-specific manner. Bioinformatic analysis of the gene signature revealed that Parkinson's Disease is caused by a perturbation of the protein folding and unfolding pathway, consistent with the formation of Lewy Body protein aggregates in patients with advanced PD. Based on the 30 gene markers, we developed the PDx™ molecular screening test that shows 100% sensitivity and 100% specificity in identifying Parkinson's Disease. PDx™ correctly detects the PD expression signature in symptomatic patients as well as in pre-symptomatic individuals 25 years before the appearance of symptoms, providing an extensive window for therapeutic intervention in pre-symptomatic patients. We are currently seeking a pharma or diagnostics strategic partner to advance PDx™ to a 510(k) FDA submission."
3 users liked this posts 2 users disliked this posts
Reply
Ignore User
|
Report Abuse
I am a big believer in Dr. Jerry...looking for further validation of the preclinical results. Funding to follow....expect a continued trading range until significant news hits.
Watch for higher lows, higher highs as we move up once again...chart looks once again as we re test and bounce of the 50 day moving avg.
Tempting to trade...but I am not risking the big news and eventually the gap up (you can have the penny or two back and forth).
The Science is stunning too...and the CEO is definitely the right guy for the job too. He is young and somewhat unproven ...but he has show savvy beyond his years (just one person's subjective opinion).
GLTA!
Thank you Dr_Jerry. Its is so uplifting to get a real credible post that discusses reality (based on fundamentals with validating data and finding the right disease to design the appropriate clinical trials ......to progress MANF in the most efficient way).
If we could only clone you and get more astute and Scientific minds here...it would be a huge relief). This board is filled with a lot of ..."know it alls".
Its fun to speculate...but its really wishful thinking. There are a lot of merger and/or partnership possibilities with AMBS. I think it will probably be one of the companies that has an Advisor on board (within AMBS).....Amgen, Pfizer, Novartis or Bayer.
Exactly! So they dilute and there are....300mm-400mm outstanding. Do people realize that this drug could potentially be a $5-$10 +++ billion dollar drug down the road (and even much more). It will take years; but if the Pharmas. validate the technology through partnerships ..the sky is the limit.
A buyout will probably happen before it gets FDA approval for multiple indications; so maybe we never reach the stratosphere (but we could get close).
They will more than likely release some significant news moving the PPS much higher; and then announce a potential dilutive deal. Big deal...that is the nature of the Biotech business and raising money.
The upside potential is 10-25 fold versus some dilution...but if they can pull non dilutive financing off ...I will be further impressed and keep buying at these levels or at least under $.25.
Risk/reward....gotta love the potential here.
Thanks for being a voice of reason! The rumors are just that...rumors. You can have fun and speculate all you want....the cat is not out of the bag and nobody really knows exactly how the future will turn out.
If you simply go to the company website and read through the news postings, videos, SEC filings, conference events, the Science and strip out all of this emotional based garbage that some people post regularly...its really not rocket science to understand how this company has one incredible future.
Buy it, tuck it away and be patient. I do think the CEO is signaling many good things to come...if you just step back and think it through...it will all work out. Lastly, the PPS continues to get hit with profit taking and some shorting activity on a short term basis...could suffer slightly and go down some more until real news hits once again. We have a winner here..let the story unfold!!!
I believe a strong base will be forming right around $.09 ..for a week or two before the BIG ONE hits....rid the shorts, weak players and keep the long term holders (and one's accumulating who are holding long and strong). As most technicians know...a strong base is extremely healthy and constructive...bodes very well for the bulls.
I agree...I am expecting a huge gap up due to a partnership or a straight acquisition by a big pharma. I wont trade this daily...would rather continue accumulating and building a more significant position.
In reality, its going up or down a penny (or two each day). Its not worth the risk of missing out on something big.
The Insider share purchases were modest in terms of share dollars. I believe Gerald is signaling to investors (that the PPS at current prices) is great value and only positive things are to come.
I love the transparency this CEO brings to the table; how can anybody doubt his credibility, intentions and future expectations?
There is no factual information that company management will not dilute (if you think so ..you are dreaming). Could they possibly pursue non dilutive financing...absolutely. I really hope that a partnership is announced with a large pharma....MANF will be a HUGE winner over time.
The Science definitely looks intriguing ..I would like to see continued data re validation by some additional credible sources. I believe their has been postings that reference Princeton as one place where validation is on going as we speak.
My goal: to accumulate over time. Typically, you may see a biotech company release great news and then its quickly followed by a dilutive financing deal ...it happens all of the time (within the biotech world).
Great question: I posted the same thing last night. I think its very important to know how long a company must (or might) delay posting news....because Insiders have bought recently.
I am guessing that materials news could take another week or two...any other thoughts? In the scheme of being a long term investor ..it many not matter.
But it might be good to know that the PPS might see some further weakness before the next inevitable blast off.
Question for the board:
How long does company mgt. have to wait to release news.....after buying shares. I am guessing that material news may have to wait until so many days/weeks after the recent Insider buying.
Hence, it was an extremely quiet week for a reason.
http://www.americanbulls.com/StockPage.asp?CompanyTicker=AMBS&MarketTicker=OTC&Typ=S
AMBS
AMARANTUS BIOSCIENCES INC
Daily Commentary
Our system posted a BUY CONFIRMED today. The previous SELL recommendation was issued on 01.16.2013 (7) days ago, when the stock price was 0.0984. Since then AMBS has gained 1.63% .
BUY-IF is confirmed by a white candlestick with a higher open. The buying price is today's open ( 0.0982 ) according to the Rules of Confirmation.
Patience pays off. The market wavered a bit but finally confirmed the recent bullish formation. The dose of the previous day was not enough for a confirmation but today it is. The market opened with a gap-up and the day’s activity resulted in a close higher than the open. This is a valid confirmation criterion. The market seems ready for a new bullish move.
The slight failure of the previous SELL signal is currently confirmed, too. We closely monitor the performance of the signals, but a few shots missing the target slightly are inevitable when you deal with the stock market. However, such signal failures are more unlikely for higher rated stocks.
We hope that you bought this stock . Today you were supposed to watch the upward gap in the opening, wait a bit, feel the bullish tendency of the market making sure that prices stay over the opening price and then go long. Your benchmark was the opening price of the upward gap.
If you bought, continue to hold this stock until the confirmation of the next SELL-IF signal. You are on safe grounds as long as the future prices continue to trade above the benchmark price and if an emergency warning is not issued. What to do if you did not buy? Maybe, you did not have time to follow the session or you simply delegated the delicate job of confirmation to us. Well it is a bit late, but not too late. You may still find suitable prices for buying in the following sessions.
The market is currently cold for short-sellers. Avoid any short sales and cover the short positions immediately if there are any. We erred on the short side last time but we hope that this is just an exception.
Data provided by: End of Day Data
BUY
CONFIRMED
0.1000
+0.0035 +3.63%
Candlestick Analysis
Today’s Candlestick Patterns:
White Spinning Top
Candlestick Pattern
Today a White Spinning Top was formed. This represents complete indecision between the bulls and the bears.
For more about this candlestick click here.
So much jealousy with the success and momentum that AMBS has brought forward lately........and will going forward. Please feel free to check back at anytime.....I will gladly share my subjective and objective feelings .....its going to be a HUGE winner!!!
These guys are really going all out here........
Amarantus BioScience (AMBS) To Be Among The First Acquisitions of 2013 As MANF Shows Positive Results Forecasts Biotech News Stock Review
by biotechnewsstockreview . 5 minutes ago . Permalink
You have a lot of catching up to do with this company (seems like an extremely myopic and distorted viewpoint on your end). Perhaps you are tied and aligned to a competitor and dont want to see this company progress with there outstanding MANF program results.
Most importantly, an AMGEN cofounder (who is on the advisory board here has publicly stated that this is one of most promising technologies he has seen in his 45 years in business).
Perhaps he was just paid to say that.....Huh?
I have repeatedly posted here (recently) that the most important step for management to take next ...is to establish the proper capital structure (hence..adequate financing).
I believe you will see some progress with the licensing side of the Diagnostic portfolio (I expect a Pharma. will step up and look to cut a deal in the near future). As the CLIA studies are progressing; the time is perfect!